The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19

The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19

Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:RESPIRATORY RESEARCH 2020-07, Vol.21 (1), p.9
Hauptverfasser: Pereira, Marcos, Paixão, Enny, Trajman, Anete, de Souza, Ramon Andrade, da Natividade, Marcio Santos, Pescarini, Julia M, Pereira, Susan Martins, Barreto, Florisneide Rodrigues, Ximenes, Ricardo, Dalcomo, Margareth, Ichihara, Maria Yury, Nunes, Ceuci, Barral-Netto, Manoel, Barreto, Maurício L
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings.
ISSN:1465-9921
DOI:10.1186/s12931-020-01439-4